Collegium Pharmaceutical, Inc.
September 29, 2016
Counsel to Collegium Pharmaceutical, Inc. in a series of related cases involving six patents owned by Purdue and related entities related to oxycodone. Obtained a judgment of invalidity of the three Orange Book listed patents in Purdue Pharma LP v. Collegium Pharm. after succeeding in a motion to transfer the action from the District of Delaware to the District of Massachusetts
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.